Insider Transactions in Q1 2025 at United Therapeutics Corp (UTHR)
Insider Transaction List (Q1 2025)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jan 21
2025
|
Michael Benkowitz PRESIDENT AND COO |
SELL
Open market or private sale
|
Indirect |
10,000
-52.82%
|
$3,650,000
$365.7 P/Share
|
|
Jan 21
2025
|
Michael Benkowitz PRESIDENT AND COO |
BUY
Exercise of conversion of derivative security
|
Indirect |
10,000
+50.0%
|
$1,110,000
$111.0 P/Share
|
|
Jan 16
2025
|
Paul A Mahon EVP & GENERAL COUNSEL |
SELL
Sale (or disposition) back to the issuer
|
Direct |
7,700
-17.34%
|
$2,818,200
$366.39 P/Share
|
|
Jan 16
2025
|
Paul A Mahon EVP & GENERAL COUNSEL |
BUY
Exercise of conversion of derivative security
|
Direct |
7,700
+14.78%
|
$1,255,100
$163.3 P/Share
|
|
Jan 13
2025
|
Michael Benkowitz PRESIDENT AND COO |
SELL
Open market or private sale
|
Indirect |
10,000
-44.11%
|
$3,640,000
$364.76 P/Share
|
|
Jan 13
2025
|
Michael Benkowitz PRESIDENT AND COO |
BUY
Exercise of conversion of derivative security
|
Indirect |
10,000
+50.0%
|
$1,110,000
$111.0 P/Share
|
|
Jan 10
2025
|
Christopher Patusky |
SELL
Open market or private sale
|
Direct |
5,000
-24.31%
|
$1,805,000
$361.39 P/Share
|
|
Jan 10
2025
|
Christopher Patusky |
BUY
Exercise of conversion of derivative security
|
Direct |
5,000
+45.87%
|
$875,000
$175.43 P/Share
|
|
Jan 06
2025
|
Michael Benkowitz PRESIDENT AND COO |
SELL
Open market or private sale
|
Indirect |
10,000
-54.37%
|
$3,560,000
$356.02 P/Share
|
|
Jan 06
2025
|
Michael Benkowitz PRESIDENT AND COO |
BUY
Exercise of conversion of derivative security
|
Indirect |
10,000
+50.0%
|
$1,110,000
$111.0 P/Share
|
|
Jan 02
2025
|
Paul A Mahon EVP & GENERAL COUNSEL |
SELL
Sale (or disposition) back to the issuer
|
Direct |
7,700
-17.34%
|
$2,772,000
$360.22 P/Share
|
|
Jan 02
2025
|
Paul A Mahon EVP & GENERAL COUNSEL |
BUY
Exercise of conversion of derivative security
|
Direct |
7,700
+14.78%
|
$1,255,100
$163.3 P/Share
|